These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17992398)

  • 21. Prognostic significance of cytogenetic abnormalities in patients with chronic myelogenous leukemia.
    Przepiorka D; Thomas ED
    Bone Marrow Transplant; 1988 Mar; 3(2):113-9. PubMed ID: 3048475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation.
    Offit K; Burns JP; Cunningham I; Jhanwar SC; Black P; Kernan NA; O'Reilly RJ; Chaganti RS
    Blood; 1990 Mar; 75(6):1346-55. PubMed ID: 2310831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China.
    Gao L; Zhang C; Gao L; Liu Y; Su Y; Wang S; Li B; Yang T; Yuan Z; Zhang X
    J Hematol Oncol; 2015 Jul; 8():90. PubMed ID: 26208715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of cytogenetic clonal evolution in chronic myelogenous leukemia.
    Majlis A; Smith TL; Talpaz M; O'Brien S; Rios MB; Kantarjian HM
    J Clin Oncol; 1996 Jan; 14(1):196-203. PubMed ID: 8558198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
    Radujkovic A; Guglielmi C; Bergantini S; Iacobelli S; van Biezen A; Milojkovic D; Gratwohl A; Schattenberg AV; Verdonck LF; Niederwieser DW; de Witte T; Kröger N; Olavarria E;
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1230-6. PubMed ID: 25797175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
    Qin YZ; Li JL; Zhu HH; Ruan GR; Li LD; Zhang Y; Xu LP; Liu DH; Liu YR; Huang XJ; Chen SS; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):511-4. PubMed ID: 17172121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular, Cytogenetic, and Hematological Analysis of Chronic Myeloid Leukemia Patients and Discovery of Two Novel Translocations.
    Asif M; Hussain A; Wali A; Ahmed N; Ali I; Iqbal Z; Amir M; Shafiq M; Rasool M
    Anal Cell Pathol (Amst); 2021; 2021():4909012. PubMed ID: 34422550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytogenetic analysis of 362 cases of chronic myeloid leukemia].
    Qiu HR; Miao KR; Qian SX; Wang R; Hong M; Qiao C; Zhang JF; Fan L; Wu HX; Lu H; Qiu HX; Chen LJ; Liu P; Zhang SJ; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):27-30. PubMed ID: 19236741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Karyotype at relapse following allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Shah NK; Wagner J; Santos G; Griffin CA
    Cancer Genet Cytogenet; 1992 Jul; 61(2):183-92. PubMed ID: 1638501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
    DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R; Jillella AP; Lonial S; Waller EK; Khoury HJ
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):466-471.e1. PubMed ID: 27297665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results.
    Holzerová M; Faber E; Veselovská J; Urbánková H; Balcárková J; Rozmanová S; Voglová J; Muzík J; Chroust K; Indrák K; Jarosová M;
    Cancer Genet Cytogenet; 2009 May; 191(1):1-9. PubMed ID: 19389502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome in chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation: the experience of the Bone Marrow Transplantation Unit of FUNFARME/BRAZIL using FISH.
    Vendrame-Goloni CB; Carvalho-Salles AB; Ruiz MA; Ricci Júnior O; Varella-Garcia M; Fett-Conte AC
    Genet Mol Res; 2008 May; 7(2):417-23. PubMed ID: 18551408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.
    Su XY; Wong N; Cao Q; Yu LZ; Niu C; Wickham N; Johnson PJ; Chen Z; Chen SJ
    Cancer Genet Cytogenet; 1999 Jan; 108(1):6-12. PubMed ID: 9973917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complex karyotype with double Philadelphia chromosome and T315I mutation results in blastic phase and extensive extramedullary infiltration in a chronic myeloid leukemia patient.
    Davulcu EA; Pekerbas M; Karaca E; Durmaz B; Özsan N; Akın H; Saydam G
    Cancer Genet; 2022 Aug; 266-267():74-80. PubMed ID: 35843036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic myeloid leukemia with variation of translocation at (Ph) [ins (22;9) (q11;q21q34)]: a case report.
    Wang Z; Zen W; Meng F; Xin X; Luo L; Sun H; Zhou J; Huang L
    Int J Clin Exp Pathol; 2015; 8(10):13707-10. PubMed ID: 26722598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
    Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft.
    Corsetti MT; Lerma E; Dejana A; Cavaliere M; Figari O; Vassallo F; Abate M; Luchetti S; Piaggio G; Parodi C; Li Pira G; Manca F; Carella AM
    Exp Hematol; 2000 Jan; 28(1):104-11. PubMed ID: 10658682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytogenetic follow-up after bone marrow transplantation for Philadelphia-positive chronic myeloid leukemia.
    Sessarego M; Frassoni F; Defferrari R; Bacigalupo A; Miceli S; Mareni C; Ajmar F
    Cancer Genet Cytogenet; 1989 Oct; 42(2):253-61. PubMed ID: 2790760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic myeloid leukemia. Karyotype changes].
    Rojas-Atencio A; Pineda-Del Villar L; Avila-León E; González-Ferrer S; Prieto-Carrasquero M; Soto M; González R
    Invest Clin; 1996 Sep; 37(3):167-75. PubMed ID: 8983354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.
    Mohamed AN; Pemberton P; Zonder J; Schiffer CA
    Clin Cancer Res; 2003 Apr; 9(4):1333-7. PubMed ID: 12684401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.